• How are GMO Regulations Impacting Clinical Development in Europe?

  • Apr 25 2024
  • Duración: 25 m
  • Podcast

How are GMO Regulations Impacting Clinical Development in Europe?  Por  arte de portada

How are GMO Regulations Impacting Clinical Development in Europe?

  • Resumen

  • In this episode of Conversations in Drug Development, our host Harriet Edwards, is joined by Director of Regulatory Affairs, Dr Sabine Ruehle, to discuss the challenges of navigating genetically modified organism (GMO) regulations in clinical trials within Europe. This discussion helps decipher the nuanced environment of GMOs and their associated risks unique within the European framework. Join us as we explore the outdated definition of GMOs, the complexities of their classification, and the impact of genome editing technologies.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre How are GMO Regulations Impacting Clinical Development in Europe?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.